Related Experiment Videos
[Diazepam versus midazolam as pre-endoscopic medication].
J A Córdova Villalobos1, R Rojas Hernández, T M Hernández Ortiz
1Universidad de Guanajuato, Facultad de Medicina de León. IMSS. Hospital de Especialidades.
Revista De Gastroenterologia De Mexico
|October 1, 1992
Summary
Midazolam offers superior sedation and patient comfort during gastrointestinal endoscopy compared to diazepam. However, midazolam is more costly and requires longer recovery times.
Area of Science:
- Gastroenterology
- Anesthesiology
- Pharmacology
Background:
- Gastrointestinal endoscopy is a common procedure requiring sedation.
- Diazepam has been a traditional choice for sedation.
- Evaluating newer agents like midazolam is crucial for improving patient experience.
Purpose of the Study:
- To compare the efficacy and safety of midazolam versus diazepam for sedation during elective gastrointestinal endoscopy.
- To assess patient-reported outcomes including sedation level, pain, and amnesia.
- To evaluate the procedural ease for endoscopists.
Main Methods:
- Prospective, randomized, double-blind study.
- 60 patients undergoing elective gastrointestinal endoscopy.
- Group A: diazepam (0.15 mg/kg); Group B: midazolam (0.10 mg/kg).
Main Results:
- Midazolam group (B) demonstrated significantly greater sedation (p < 0.05).
- Patients receiving midazolam reported less injection site pain and enhanced retrograde amnesia.
- Midazolam was associated with better overall procedure tolerance without increased complications.
- Midazolam's cost per dose was double that of diazepam.
Conclusions:
- Midazolam presents advantages over diazepam for gastrointestinal endoscopy sedation, including improved sedation and patient tolerance.
- Key disadvantages of midazolam include higher cost and extended recovery time.
- Further research may explore optimized dosing or combination therapies to mitigate midazolam's drawbacks.